Reported covered position: Staff Assist., Senate Energy & Natural Re. Com.
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: AVENUE SOLUTIONS
H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; Kidney care issues; FY27 LHHS and Mil-Con appropriations report language
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: AVENUE SOLUTIONS
H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; Kidney care issues; FY27 LHHS and Mil-Con appropriations report language
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
VERTEX PHARMACEUTICALS INCORPORATED via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Monitor issues related to 340b;
H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; Kidney care issues; FY27 LHHS and Mil-Con appropriations report language
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
| FRESENIUS MEDICAL CARE NORTH AMERICA |
| 42 |
| 2016–2026 |
| NATIONAL ELECTRICAL MANUFACTURERS ASSN (FOR ACCESS TO MEDICAL IMAGING COALITION) | 37 | 2009–2018 |
| DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. | 35 | 2014–2024 |
| PEDIATRIX MEDICAL GROUP, INC. | 29 | 2016–2024 |
| BLUE CROSS AND BLUE SHIELD ASSOCIATION | 28 | 2009–2024 |
| NCTA - THE INTERNET & TELEVISION ASSOCIATION | 28 | 2009–2019 |
| AMEDISYS HOME HEALTH AND HOSPICE CARE | 25 | 2018–2024 |
| AMERICAN MEDICAL ASSOCIATION | 25 | 2016–2024 |
| EXPRESS SCRIPTS INC | 25 | 2009–2015 |
| SAGE THERAPEUTICS, INC. | 24 | 2019–2024 |
| INCYTE CORPORATION | 21 | 2019–2025 |
| EDWARDS LIFESCIENCES LLC | 18 | 2021–2026 |
| GRAIL, Inc. | 17 | 2020–2024 |
| AETNA | 16 | 2009–2012 |
| GENENTECH USA, INC. | 16 | 2021–2025 |
| HOSPICE ACTION NETWORK | 16 | 2014–2017 |
| KIDNEY CARE COUNCIL | 16 | 2015–2018 |
| TRAVELERS COMPANIES INC | 16 | 2009–2012 |
| CUBIST PHARMACEUTICALS, INC. | 13 | 2012–2014 |
| JAZZ PHARMACEUTICALS INC. | 13 | 2012–2015 |
| NATIONAL FAMILY PLANNING AND REPRODUCTIVE HEALTH ASSOCIATION | 12 | 2015–2019 |
| ZELIS HEALTHCARE CORP. | 12 | 2021–2023 |
| INDEPENDENT INSURANCE AGENTS & BROKERS OF AMERICA, INC. | 11 | 2013–2015 |
| GAINWELL TECHNOLOGIES | 10 | 2020–2022 |
| HELP AT HOME | 10 | 2023–2025 |
| IOVANCE BIOTHERAPEUTICS, INC. | 10 | 2020–2022 |
| MATRIX MEDICAL NETWORK | 10 | 2021–2023 |
| RICHIE'S SPECIALTY PHARMACY | 10 | 2013–2015 |
| VERTEX PHARMACEUTICALS INCORPORATED | 10 | 2023–2026 |
| MERCK & CO., INC. | 9 | 2015–2024 |
| MASSACHUSETTS 2020 | 8 | 2009–2010 |
| NATIONAL ALLIANCE FOR CARE AT HOME | 8 | 2025–2026 |
| OAK STREET HEALTH MSO, LLC | 8 | 2021–2022 |
| UNITED PARCEL SERVICE (UPS) | 8 | 2010–2012 |
| SIEMENS MEDICAL SOLUTIONS USA, INC | 7 | 2023–2024 |
| BRAVO HEALTH, INC. | 6 | 2009–2010 |
| HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION | 6 | 2020–2021 |
| COALITION TO STRENGTHEN THE FUTURE OF MOLECULAR DIAGNOSTICS | 5 | 2013 |
| JPMORGAN CHASE HOLDINGS LLC | 5 | 2020–2024 |
| SIMPLIFED, INC. | 5 | 2022 |
| ADVANCED MEDICAL TECHNOLOGY ASSOCIATION (ADVAMED) | 4 | 2015 |
| CENTER FOR TECHNOLOGY COMMERCIALIZATION | 4 | 2009 |
| GROUP HEALTH COOPERATIVE | 4 | 2014–2015 |
| ILLUMINA, INC. | 4 | 2019–2020 |
| KARUNA THERAPEUTICS, INC. | 4 | 2023–2024 |
| ORACLE CORPORATION | 4 | 2022 |
| ROUTE 66 VENTURES, LLC | 4 | 2009 |
| TESARO, INC. | 4 | 2018–2019 |
| AIM EDUCATION, INC. | 3 | 2009 |
| COMPASS PATHWAYS, INC. | 3 | 2026 |
| GINGER.IO, INC. | 3 | 2021 |
| MOMENTA PHARMACEUTICALS, INC. | 3 | 2013–2015 |
| ORGANIC VOICES ACTION FUND | 3 | 2015 |
| TOBACCO FREE KIDS ACTION FUND | 3 | 2022 |
| VIROPHARMA INCORPORATED | 3 | 2012 |
| VISITING NURSE SERVICE OF NEW YORK | 3 | 2014 |
| ALLIANCE FOR REGENERATIVE MEDICINE | 2 | 2023–2024 |
| NELNET INC | 2 | 2013 |
| BIOVERATIV INC. | 1 | 2017 |
| UNIVERSAL AMERICAN FINANCIAL SERVICES (FOR COLLABORATIVE HEALTH SYSTEMS) | 1 | 2016 |
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: AVENUE SOLUTIONS
H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process
Restore Protections for Dialysis Patients Act
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: AVENUE SOLUTIONS
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: AVENUE SOLUTIONS
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Restore Protections for Dialysis Patients Act
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: AVENUE SOLUTIONS
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Proposed Rule - CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney Injury Dialysis (AKI) Payment, and ESRD Quality Incentive Program; Market Basket Update in CY 2027 ESRD PPS; Low Volume Payment Adjustment eligibility in CY 2027 ESRD PPS; Medicare forecast error adjustment in ESRD PPS
Restore Protections for Dialysis Patients Act
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: AVENUE SOLUTIONS
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Seniors’ Access to Critical Medications Act of 2025
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) · Firm: AVENUE SOLUTIONS
H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to in-office dispensing of medication regulations
To amend title XVIII to reform the Medicare Advantage program.
Client: SNP ALLIANCE INC · Firm: AVENUE SOLUTIONS
Medicare and Medicaid dual eligible integration; Issues related to Medicare Advantage, including automatic enrollment and assignment, benchmark setting for payment, health risk assessments and chart review, hospice and MA, prior authorization, quality and star ratings, two years of data for payment; S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; Medicare Advantage (MA) quality Star ratings
To amend title XVIII to reform the Medicare Advantage program.
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; Home Health Perspective Payment System (HH PPS) Final Rule for CY 2026 (CMS-1828-F); H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice MA Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process
To amend title XVIII to reform the Medicare Advantage program.
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; Home Health Perspective Payment System (HH PPS) Final Rule for CY 2026 (CMS-1828-F); H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice MA Carve-in
To amend title XVIII to reform the Medicare Advantage program.
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice Medicare Advantage Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratoria on Enrollment of Home Health Agencies (HHAs) CMS issued on 5/13/26; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratorium on Enrollment of Hospices CMS issued on 5/13/26; Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies; S. 5250, Medicare Home Health Payment Integrity and Protection Act; DEAs registration pathway letting practitioners prescribe controlled substances via telemedicine without a prior in-person evaluation under the Ryan Haight Act; Medicare Advantage Home Health Network Adequacy; H.R. 8375, S. 4384, Medicare Advantage Improvement Act of 2026
To amend title XVIII to reform the Medicare Advantage program.
Client: SNP ALLIANCE INC · Firm: AVENUE SOLUTIONS
Medicare and Medicaid dual eligible integration; Issues related to Medicare Advantage, including automatic enrollment and assignment, benchmark setting for payment, health risk assessments and chart review, hospice and MA, prior authorization, quality and star ratings, two years of data for payment; S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; Medicare Advantage (MA) quality Star Ratings
To amend title XVIII to reform the Medicare Advantage program.
Client: SNP ALLIANCE INC · Firm: AVENUE SOLUTIONS
Medicare and Medicaid dual eligible integration; Issues related to Medicare Advantage, including automatic enrollment and assignment, benchmark setting for payment, health risk assessments and chart review, hospice and MA, prior authorization, quality and star ratings, two years of data for payment; S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; Medicare Advantage (MA) quality Star ratings
Protecting Patient Access to Cancer and Complex Therapies Act
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) · Firm: AVENUE SOLUTIONS
H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to in-office dispensing of medication regulations
Home Health Stabilization Act of 2025
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; Home Health Perspective Payment System (HH PPS) Final Rule for CY 2026 (CMS-1828-F); H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice MA Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process
Home Health Stabilization Act of 2025
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; Home Health Perspective Payment System (HH PPS) Final Rule for CY 2026 (CMS-1828-F); H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice MA Carve-in
Home Health Stabilization Act of 2025
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice Medicare Advantage Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratoria on Enrollment of Home Health Agencies (HHAs) CMS issued on 5/13/26; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratorium on Enrollment of Hospices CMS issued on 5/13/26; Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies; S. 5250, Medicare Home Health Payment Integrity and Protection Act; DEAs registration pathway letting practitioners prescribe controlled substances via telemedicine without a prior in-person evaluation under the Ryan Haight Act; Medicare Advantage Home Health Network Adequacy; H.R. 8375, S. 4384, Medicare Advantage Improvement Act of 2026
Ensuring Patient Access to Critical Breakthrough Products Act
Client: EDWARDS LIFESCIENCES LLC · Firm: AVENUE SOLUTIONS
Issues related to CMSs draft coverage policy for transcatheter aortic valve replacement (TAVR) issued June 15, 2026; Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Issues related to Senate Finance Dear Colleague process
Ensuring Patient Access to Critical Breakthrough Products Act
Client: EDWARDS LIFESCIENCES LLC · Firm: AVENUE SOLUTIONS
Issues related to CMSs draft coverage policy for transcatheter aortic valve replacement (TAVR) issued June 15, 2026; Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Issues related to Senate Finance Dear Colleague process
Ensuring Patient Access to Critical Breakthrough Products Act
Client: EDWARDS LIFESCIENCES LLC · Firm: AVENUE SOLUTIONS
Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders; Issues related to Senate Finance Dear Colleague process
Patients Deserve Price Tags Act
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) · Firm: AVENUE SOLUTIONS
Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
Kidney Care Access Protection Act
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: AVENUE SOLUTIONS
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Kidney Care Access Protection Act
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: AVENUE SOLUTIONS
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Kidney Care Access Protection Act
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: AVENUE SOLUTIONS
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Proposed Rule - CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney Injury Dialysis (AKI) Payment, and ESRD Quality Incentive Program; Market Basket Update in CY 2027 ESRD PPS; Low Volume Payment Adjustment eligibility in CY 2027 ESRD PPS; Medicare forecast error adjustment in ESRD PPS
Medicare Advantage Improvement Act of 2026
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice Medicare Advantage Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratoria on Enrollment of Home Health Agencies (HHAs) CMS issued on 5/13/26; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratorium on Enrollment of Hospices CMS issued on 5/13/26; Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies; S. 5250, Medicare Home Health Payment Integrity and Protection Act; DEAs registration pathway letting practitioners prescribe controlled substances via telemedicine without a prior in-person evaluation under the Ryan Haight Act; Medicare Advantage Home Health Network Adequacy; H.R. 8375, S. 4384, Medicare Advantage Improvement Act of 2026
Protecting Seniors and Stopping Fraudsters Act
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice Medicare Advantage Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratoria on Enrollment of Home Health Agencies (HHAs) CMS issued on 5/13/26; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratorium on Enrollment of Hospices CMS issued on 5/13/26; Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies; S. 5250, Medicare Home Health Payment Integrity and Protection Act; DEAs registration pathway letting practitioners prescribe controlled substances via telemedicine without a prior in-person evaluation under the Ryan Haight Act; Medicare Advantage Home Health Network Adequacy; H.R. 8375, S. 4384, Medicare Advantage Improvement Act of 2026
Protecting Seniors and Stopping Fraudsters Act
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; Home Health Perspective Payment System (HH PPS) Final Rule for CY 2026 (CMS-1828-F); H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice MA Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process
Lower Costs, More Transparency Act of 2026
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) · Firm: AVENUE SOLUTIONS
Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
Tax Exempt Hospital Transparency Act
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) · Firm: AVENUE SOLUTIONS
Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, health risk assessments, prompt pay, and brokers; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; S. 1105, No UPCODE Act; Issues related to street medicine; MedPAC nomination process; Issues related to Senate Finance Dear Colleague process
Medicare and Medicaid dual eligible integration; Issues related to Medicare Advantage, including automatic enrollment and assignment, benchmark setting for payment, health risk assessments and chart review, hospice and MA, prior authorization, quality and star ratings, two years of data for payment; S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; Medicare Advantage (MA) quality Star ratings
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, health risk assessments, prompt pay, and brokers; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; S. 1105, No UPCODE Act; Issues related to street medicine; MedPAC nomination process; Issues related to Senate Finance Dear Colleague process
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, health risk assessments, prompt pay, and brokers; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; S. 1105, No UPCODE Act; Issues related to street medicine; MedPAC nomination process; Issues related to Senate Finance Dear Colleague process
Medicare and Medicaid dual eligible integration; Issues related to Medicare Advantage, including automatic enrollment and assignment, benchmark setting for payment, health risk assessments and chart review, hospice and MA, prior authorization, quality and star ratings, two years of data for payment; S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; Medicare Advantage (MA) quality Star ratings
Medicare and Medicaid dual eligible integration; Issues related to Medicare Advantage, including automatic enrollment and assignment, benchmark setting for payment, health risk assessments and chart review, hospice and MA, prior authorization, quality and star ratings, two years of data for payment; S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; Medicare Advantage (MA) quality Star Ratings
Restore Protections for Dialysis Patients Act
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: AVENUE SOLUTIONS
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Restore Protections for Dialysis Patients Act
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: AVENUE SOLUTIONS
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: AVENUE SOLUTIONS
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Restore Protections for Dialysis Patients Act
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: AVENUE SOLUTIONS
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Proposed Rule - CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney Injury Dialysis (AKI) Payment, and ESRD Quality Incentive Program; Market Basket Update in CY 2027 ESRD PPS; Low Volume Payment Adjustment eligibility in CY 2027 ESRD PPS; Medicare forecast error adjustment in ESRD PPS
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: EDWARDS LIFESCIENCES LLC · Firm: AVENUE SOLUTIONS
Issues related to CMSs draft coverage policy for transcatheter aortic valve replacement (TAVR) issued June 15, 2026; Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Issues related to Senate Finance Dear Colleague process
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: EDWARDS LIFESCIENCES LLC · Firm: AVENUE SOLUTIONS
Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders; Issues related to Senate Finance Dear Colleague process
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
Client: EDWARDS LIFESCIENCES LLC · Firm: AVENUE SOLUTIONS
Issues related to CMSs draft coverage policy for transcatheter aortic valve replacement (TAVR) issued June 15, 2026; Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Issues related to Senate Finance Dear Colleague process
Patients Deserve Price Tags Act
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) · Firm: AVENUE SOLUTIONS
Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
Kidney Care Access Protection Act
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: AVENUE SOLUTIONS
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Proposed Rule - CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney Injury Dialysis (AKI) Payment, and ESRD Quality Incentive Program; Market Basket Update in CY 2027 ESRD PPS; Low Volume Payment Adjustment eligibility in CY 2027 ESRD PPS; Medicare forecast error adjustment in ESRD PPS
Kidney Care Access Protection Act
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: AVENUE SOLUTIONS
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Kidney Care Access Protection Act
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: AVENUE SOLUTIONS
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Medicare Advantage Improvement Act of 2026
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice Medicare Advantage Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratoria on Enrollment of Home Health Agencies (HHAs) CMS issued on 5/13/26; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratorium on Enrollment of Hospices CMS issued on 5/13/26; Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies; S. 5250, Medicare Home Health Payment Integrity and Protection Act; DEAs registration pathway letting practitioners prescribe controlled substances via telemedicine without a prior in-person evaluation under the Ryan Haight Act; Medicare Advantage Home Health Network Adequacy; H.R. 8375, S. 4384, Medicare Advantage Improvement Act of 2026
H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process
H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; Kidney care issues; FY27 LHHS and Mil-Con appropriations report language
H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; Kidney care issues; FY27 LHHS and Mil-Con appropriations report language
Medicare Home Health Payment Integrity and Protection Act of 2026
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice Medicare Advantage Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratoria on Enrollment of Home Health Agencies (HHAs) CMS issued on 5/13/26; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratorium on Enrollment of Hospices CMS issued on 5/13/26; Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies; S. 5250, Medicare Home Health Payment Integrity and Protection Act; DEAs registration pathway letting practitioners prescribe controlled substances via telemedicine without a prior in-person evaluation under the Ryan Haight Act; Medicare Advantage Home Health Network Adequacy; H.R. 8375, S. 4384, Medicare Advantage Improvement Act of 2026
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: EDWARDS LIFESCIENCES LLC · Firm: AVENUE SOLUTIONS
Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14. (Public Law No: 119-21)
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: HELP AT HOME · Firm: AVENUE SOLUTIONS
Issues related to home care and home and community based services (HCBS); Ensuring Access to Medicaid Services (CMS-2442-F); New York Medicaid Consumer-Directed Personal Assistance Program; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21)
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21); CY 2026 Home Health Proposed Rule; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program.
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: SCAN HEALTH PLAN · Firm: AVENUE SOLUTIONS
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21); S. 1105, No UPCODE Act; Issues related to street medicine
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: SNP ALLIANCE INC · Firm: AVENUE SOLUTIONS
Medicare and Medicaid dual eligible integration; Performance evaluation/quality oversight; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21); S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program.
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: KIDNEY CARE PARTNERS · Firm: AVENUE SOLUTIONS
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; Medicare forecast error adjustment in ESRD PPS; Reauthorization of enhanced Advance Premium Tax Credits (APTC); Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21)
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: AVENUE SOLUTIONS
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; Medicare forecast error adjustment in ESRD PPS; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14. (Public Law No: 119-21)
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21); CY 2026 Home Health Proposed Rule; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: EDWARDS LIFESCIENCES LLC · Firm: AVENUE SOLUTIONS
Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14. (Public Law No: 119-21)
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: HELP AT HOME · Firm: AVENUE SOLUTIONS
Issues related to home care and home and community based services (HCBS); Ensuring Access to Medicaid Services (CMS-2442-F); New York Medicaid Consumer-Directed Personal Assistance Program; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21)
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SCAN HEALTH PLAN · Firm: AVENUE SOLUTIONS
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21); S. 1105, No UPCODE Act; Issues related to street medicine
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: SNP ALLIANCE INC · Firm: AVENUE SOLUTIONS
Medicare and Medicaid dual eligible integration; Performance evaluation/quality oversight; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21); S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: KIDNEY CARE PARTNERS · Firm: AVENUE SOLUTIONS
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; Medicare forecast error adjustment in ESRD PPS; Reauthorization of enhanced Advance Premium Tax Credits (APTC); Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21)
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: AVENUE SOLUTIONS
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; Medicare forecast error adjustment in ESRD PPS; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14. (Public Law No: 119-21)
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: HELP AT HOME · Firm: AVENUE SOLUTIONS
Issues related to home care and home and community based services (HCBS); Ensuring Access to Medicaid Services (CMS-2442-F); New York Medicaid Consumer-Directed Personal Assistance Program; S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4)
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: EDWARDS LIFESCIENCES LLC · Firm: AVENUE SOLUTIONS
Issues related to the CMS Rule: Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4); Medicare coverage of breakthrough technologies
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: AVENUE SOLUTIONS
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4)
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: SNP ALLIANCE INC · Firm: AVENUE SOLUTIONS
S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4)
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4)
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: GENENTECH USA, INC. · Firm: AVENUE SOLUTIONS
Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Issues related to the expiration/extension of Priority Review Vouchers (PRVs) for rare disease; Issues related to 340b drug pricing program; S. 891, Bipartisan Health Care Act H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4)
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: KIDNEY CARE PARTNERS · Firm: AVENUE SOLUTIONS
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4); Issues related to innovation in Mediare payments
Full-Year Continuing Appropriations and Extensions Act, 2025
Client: SCAN HEALTH PLAN · Firm: AVENUE SOLUTIONS
S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4); Issues related to street medicine
Restore Protections for Dialysis Patients Act
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: AVENUE SOLUTIONS
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Restore Protections for Dialysis Patients Act
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: AVENUE SOLUTIONS
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4)
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: AVENUE SOLUTIONS
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; Medicare forecast error adjustment in ESRD PPS; Reauthorization of enhanced Advance Premium Tax Credits (APTC); Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21)
Restore Protections for Dialysis Patients Act
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: AVENUE SOLUTIONS
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: AVENUE SOLUTIONS
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4); Issues related to innovation in Mediare payments
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: AVENUE SOLUTIONS
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS; Reauthorization of enhanced Advance Premium Tax Credits (APTC)
Restore Protections for Dialysis Patients Act
Client: KIDNEY CARE PARTNERS · Firm: AVENUE SOLUTIONS
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Restore Protections for Dialysis Patients Act
Client: FRESENIUS MEDICAL CARE NORTH AMERICA · Firm: AVENUE SOLUTIONS
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; Medicare forecast error adjustment in ESRD PPS; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14. (Public Law No: 119-21)
Seniors’ Access to Critical Medications Act of 2025
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) · Firm: AVENUE SOLUTIONS
H.R. 2484, Seniors Access to Critical Medications Act; Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to the extension of telehealth services; Issues related to site neutral payments
Seniors’ Access to Critical Medications Act of 2025
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) · Firm: AVENUE SOLUTIONS
H.R. 2484, Seniors Access to Critical Medications Act; Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
To amend title XVIII to reform the Medicare Advantage program.
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21); CY 2026 Home Health Proposed Rule; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program.
To amend title XVIII to reform the Medicare Advantage program.
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; Home Health Perspective Payment System (HH PPS) Final Rule for CY 2026 (CMS-1828-F); H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice MA Carve-in
To amend title XVIII to reform the Medicare Advantage program.
Client: SNP ALLIANCE INC · Firm: AVENUE SOLUTIONS
Medicare and Medicaid dual eligible integration; Issues related to Medicare Advantage, including automatic enrollment and assignment, benchmark setting for payment, health risk assessments and chart review, hospice and MA, prior authorization, quality and star ratings, two years of data for payment; S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program.
To amend title XVIII to reform the Medicare Advantage program.
Client: SNP ALLIANCE INC · Firm: AVENUE SOLUTIONS
Medicare and Medicaid dual eligible integration; Issues related to Medicare Advantage, including automatic enrollment and assignment, benchmark setting for payment, health risk assessments and chart review, hospice and MA, prior authorization, quality and star ratings, two years of data for payment; S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program.
To amend title XVIII to reform the Medicare Advantage program.
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; CY 2026 Home Health Proposed Rule; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice MA Carve-in
To amend title XVIII to reform the Medicare Advantage program.
Client: SNP ALLIANCE INC · Firm: AVENUE SOLUTIONS
Medicare and Medicaid dual eligible integration; Performance evaluation/quality oversight; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21); S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program.
Protecting Patient Access to Cancer and Complex Therapies Act
Client: LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) · Firm: AVENUE SOLUTIONS
H.R. 2484, Seniors Access to Critical Medications Act; Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Home Health Stabilization Act of 2025
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; CY 2026 Home Health Proposed Rule; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice MA Carve-in
Home Health Stabilization Act of 2025
Client: NATIONAL ALLIANCE FOR CARE AT HOME · Firm: AVENUE SOLUTIONS
Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; Home Health Perspective Payment System (HH PPS) Final Rule for CY 2026 (CMS-1828-F); H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice MA Carve-in
Ensuring Patient Access to Critical Breakthrough Products Act
Client: EDWARDS LIFESCIENCES LLC · Firm: AVENUE SOLUTIONS
Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Expiring healthcare extenders
Ensuring Patient Access to Critical Breakthrough Products Act
Client: EDWARDS LIFESCIENCES LLC · Firm: AVENUE SOLUTIONS
Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Expiring healthcare extenders
Medicare and Medicaid dual eligible integration; Issues related to Medicare Advantage, including automatic enrollment and assignment, benchmark setting for payment, health risk assessments and chart review, hospice and MA, prior authorization, quality and star ratings, two years of data for payment; S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program.
Medicare and Medicaid dual eligible integration; Performance evaluation/quality oversight; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21); S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program.
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21); S. 1105, No UPCODE Act; Issues related to street medicine
SNP ALLIANCE INC via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Medicare and Medicaid dual eligible integration; Issues related to Medicare Advantage, including automatic enrollment and assignment, benchmark setting for payment, health risk assessments and chart review, hospice and MA, prior authorization, quality and star ratings, two years of data for payment; S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; Medicare Advantage (MA) quality Star Ratings
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, health risk assessments, prompt pay, and brokers; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; S. 1105, No UPCODE Act; Issues related to street medicine; MedPAC nomination process; Issues related to Senate Finance Dear Colleague process
Filing targets: SENATE
NATIONAL ALLIANCE FOR CARE AT HOME via AVENUE SOLUTIONS
2026 · third_quarter · Q3
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice Medicare Advantage Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratoria on Enrollment of Home Health Agencies (HHAs) CMS issued on 5/13/26; Medicare, Medicaid, and Children's Health Insurance Programs: Announcement of Nationwide Temporary Moratorium on Enrollment of Hospices CMS issued on 5/13/26; Calendar Year 2027 Home Health Prospective Payment System (HH PPS) Rate Update; Requirements for the HH Quality Reporting Program and the Expanded HH Value-Based Purchasing Model; Medicare Provider Enrollment, Durable Medical Equipment (DME), and DME, Prosthetics, Orthotics, and Supplies (DMEPOS) Policies; S. 5250, Medicare Home Health Payment Integrity and Protection Act; DEAs registration pathway letting practitioners prescribe controlled substances via telemedicine without a prior in-person evaluation under the Ryan Haight Act; Medicare Advantage Home Health Network Adequacy; H.R. 8375, S. 4384, Medicare Advantage Improvement Act of 2026
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Proposed Rule - CY 2027 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment System, Acute Kidney Injury Dialysis (AKI) Payment, and ESRD Quality Incentive Program; Market Basket Update in CY 2027 ESRD PPS; Low Volume Payment Adjustment eligibility in CY 2027 ESRD PPS; Medicare forecast error adjustment in ESRD PPS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES LLC via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to CMSs draft coverage policy for transcatheter aortic valve replacement (TAVR) issued June 15, 2026; Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Issues related to Senate Finance Dear Colleague process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMPASS PATHWAYS, INC. via AVENUE SOLUTIONS
2026 · third_quarter · Q3
Issues related to innovative treatment for mental health and PTSD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERTEX PHARMACEUTICALS INCORPORATED via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Monitor issues related to 340b;
H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process; Kidney care issues; FY27 LHHS and Mil-Con appropriations report language
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SNP ALLIANCE INC via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Medicare and Medicaid dual eligible integration; Issues related to Medicare Advantage, including automatic enrollment and assignment, benchmark setting for payment, health risk assessments and chart review, hospice and MA, prior authorization, quality and star ratings, two years of data for payment; S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; Medicare Advantage (MA) quality Star ratings
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, health risk assessments, prompt pay, and brokers; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; S. 1105, No UPCODE Act; Issues related to street medicine; MedPAC nomination process; Issues related to Senate Finance Dear Colleague process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ALLIANCE FOR CARE AT HOME via AVENUE SOLUTIONS
2026 · second_quarter · Q2
H.R. 8883, Protecting Seniors and Stopping Fraudsters Act; Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; Home Health Perspective Payment System (HH PPS) Final Rule for CY 2026 (CMS-1828-F); H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice MA Carve-in; Issues related to Medicare and Medicaid fraud; Issues related to Senate Finance Dear Colleague Process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) via AVENUE SOLUTIONS
2026 · second_quarter · Q2
H.R. 2484, Seniors Access to Critical Medications Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to in-office dispensing of medication regulations
Issues related to 340b; H.R. 9393, Lower Costs, More Transparency Act; H.R. 5582 / S. 2355, Patients Deserve Price Tags Act; H.R. 9504, Tax Exempt Hospital Transparency Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES LLC via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Issues related to CMSs draft coverage policy for transcatheter aortic valve replacement (TAVR) issued June 15, 2026; Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Issues related to Senate Finance Dear Colleague process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMPASS PATHWAYS, INC. via AVENUE SOLUTIONS
2026 · second_quarter · Q2
Issues related to innovative treatment for mental health and PTSD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
COMPASS PATHWAYS, INC. via AVENUE SOLUTIONS
2026 · second_quarter · RR
Issues related to innovative treatment for mental health and PTSD.
VERTEX PHARMACEUTICALS INCORPORATED via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Monitor issues related to 340b; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC)
H.R. 1227/S. 475, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to Senate Finance Dear Colleague process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SNP ALLIANCE INC via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC)
Medicare and Medicaid dual eligible integration; Issues related to Medicare Advantage, including automatic enrollment and assignment, benchmark setting for payment, health risk assessments and chart review, hospice and MA, prior authorization, quality and star ratings, two years of data for payment; S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; Medicare Advantage (MA) quality Star ratings
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, health risk assessments, prompt pay, and brokers; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; S. 1105, No UPCODE Act; Issues related to street medicine; MedPAC nomination process; Issues related to Senate Finance Dear Colleague process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ALLIANCE FOR CARE AT HOME via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC)
Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; Home Health Perspective Payment System (HH PPS) Final Rule for CY 2026 (CMS-1828-F); H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice MA Carve-in
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CARE PARTNERS via AVENUE SOLUTIONS
2026 · first_quarter · 1T
Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders; Reauthorization of enhanced Advance Premium Tax Credits (APTC)
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders and expiring Advanced Premium Tax Credits (APTC)
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730/H.R. 6214, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES LLC via AVENUE SOLUTIONS
2026 · first_quarter · Q1
Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Public Law No: 119-75, Consolidated Appropriations Act, 2026 - issues related to expiring healthcare extenders; Issues related to Senate Finance Dear Colleague process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SNP ALLIANCE INC via AVENUE SOLUTIONS
2025 · fourth_quarter · Q4
Medicare and Medicaid dual eligible integration; Issues related to Medicare Advantage, including automatic enrollment and assignment, benchmark setting for payment, health risk assessments and chart review, hospice and MA, prior authorization, quality and star ratings, two years of data for payment; S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program.
Expiring healthcare extenders
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via AVENUE SOLUTIONS
2025 · fourth_quarter · Q4
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, health risk assessments, prompt pay, and brokers; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; S. 1105, No UPCODE Act; Issues related to street medicine
Expiring healthcare extenders
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ALLIANCE FOR CARE AT HOME via AVENUE SOLUTIONS
2025 · fourth_quarter · Q4
Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; Home Health Perspective Payment System (HH PPS) Final Rule for CY 2026 (CMS-1828-F); H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice MA Carve-in
Expiring healthcare extenders; Expiring telehealth extender
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CARE PARTNERS via AVENUE SOLUTIONS
2025 · fourth_quarter · Q4
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Expiring healthcare extenders; Reauthorization of enhanced Advance Premium Tax Credits (APTC)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HELP AT HOME via AVENUE SOLUTIONS
2025 · fourth_quarter · Q4
Issues related to home care and home and community based services (HCBS); Ensuring Access to Medicaid Services (CMS-2442-F)
Expiring healthcare extenders
FRESENIUS MEDICAL CARE NORTH AMERICA via AVENUE SOLUTIONS
2025 · fourth_quarter · Q4
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Expiring healthcare extenders; Reauthorization of enhanced Advance Premium Tax Credits (APTCs)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES LLC via AVENUE SOLUTIONS
2025 · fourth_quarter · Q4
Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Expiring healthcare extenders
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SNP ALLIANCE INC via AVENUE SOLUTIONS
2025 · third_quarter · Q3
Medicare and Medicaid dual eligible integration; Issues related to Medicare Advantage, including automatic enrollment and assignment, benchmark setting for payment, health risk assessments and chart review, hospice and MA, prior authorization, quality and star ratings, two years of data for payment; S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program.
Expiring healthcare extenders
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via AVENUE SOLUTIONS
2025 · third_quarter · Q3
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, health risk assessments, prompt pay, and brokers; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; S. 1105, No UPCODE Act; Issues related to street medicine
Expiring healthcare extenders
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ALLIANCE FOR CARE AT HOME via AVENUE SOLUTIONS
2025 · third_quarter · Q3
Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; CY 2026 Home Health Proposed Rule; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program; H.R. 5142, Home Health Stabilization Act of 2025; Hospice MA Carve-in
Expiring healthcare extenders
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CARE PARTNERS via AVENUE SOLUTIONS
2025 · third_quarter · Q3
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS; Reauthorization of enhanced Advance Premium Tax Credits (APTC)
Expiring healthcare extenders
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HELP AT HOME via AVENUE SOLUTIONS
2025 · third_quarter · Q3
Issues related to home care and home and community based services (HCBS); Ensuring Access to Medicaid Services (CMS-2442-F); New York Medicaid Consumer-Directed Personal Assistance Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via AVENUE SOLUTIONS
2025 · third_quarter · Q3
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; S. 2730, Kidney Care Access Protection Act; Medicare forecast error adjustment in ESRD PPS
Expiring healthcare extenders; Reauthorization of enhanced Advance Premium Tax Credits (APTCs)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES LLC via AVENUE SOLUTIONS
2025 · third_quarter · Q3
Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 5343/S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Expiring healthcare extenders
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SNP ALLIANCE INC via AVENUE SOLUTIONS
2025 · second_quarter · Q2
Medicare and Medicaid dual eligible integration; Performance evaluation/quality oversight; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21); S. 1105, No UPCODE Act; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via AVENUE SOLUTIONS
2025 · second_quarter · Q2
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21); S. 1105, No UPCODE Act; Issues related to street medicine
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ALLIANCE FOR CARE AT HOME via AVENUE SOLUTIONS
2025 · second_quarter · Q2
Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21); CY 2026 Home Health Proposed Rule; H.R. 3467, To amend title XVIII to reform the Medicare Advantage program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) via AVENUE SOLUTIONS
2025 · second_quarter · Q2
H.R. 2484, Seniors Access to Critical Medications Act; Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to the extension of telehealth services; Issues related to site neutral payments; Issues related to 2024 Physician Fee Schedule and physician payment reform; H.R. 4299, Protecting Patient Access to Cancer and Complex Therapies Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CARE PARTNERS via AVENUE SOLUTIONS
2025 · second_quarter · Q2
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; Medicare forecast error adjustment in ESRD PPS; Reauthorization of enhanced Advance Premium Tax Credits (APTC); Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HELP AT HOME via AVENUE SOLUTIONS
2025 · second_quarter · Q2
Issues related to home care and home and community based services (HCBS); Ensuring Access to Medicaid Services (CMS-2442-F); New York Medicaid Consumer-Directed Personal Assistance Program; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14 (Public Law No: 119-21)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via AVENUE SOLUTIONS
2025 · second_quarter · Q2
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; Barriers to innovation in the ESRD PPS and Medicare Advantage programs; Medicare forecast error adjustment in ESRD PPS; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14. (Public Law No: 119-21)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES LLC via AVENUE SOLUTIONS
2025 · second_quarter · Q2
Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act of 2025; Health care issues in H.R. 1, To provide for reconciliation pursuant to title II of H. Con. Res. 14. (Public Law No: 119-21)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via AVENUE SOLUTIONS
2025 · first_quarter · Q1
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices, provider directories and prior authorization;
S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4); Issues related to street medicine
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SNP ALLIANCE INC via AVENUE SOLUTIONS
2025 · first_quarter · Q1
Medicare and Medicaid dual eligible integration; Performance evaluation/quality oversight; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices
S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ALLIANCE FOR CARE AT HOME via AVENUE SOLUTIONS
2025 · first_quarter · Q1
Medicare Home Health benefit; Medicaid Home and Community-Based Services (HCBS) benefits; Medicare Hospice benefit; S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) via AVENUE SOLUTIONS
2025 · first_quarter · Q1
H.R. 2484, Seniors Access to Critical Medications Act; Protecting Patient Access to Cancer and Complex Therapies Act; Issues related to the extension of telehealth services; Issues related to site neutral payments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CARE PARTNERS via AVENUE SOLUTIONS
2025 · first_quarter · Q1
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4); Issues related to innovation in Mediare payments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INCYTE CORPORATION via AVENUE SOLUTIONS
2025 · first_quarter · Q1
Issues related to 340b
Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation; Issues related to Medicaid rebates
Filing targets: SENATE
HELP AT HOME via AVENUE SOLUTIONS
2025 · first_quarter · Q1
Issues related to home care and home and community based services (HCBS); Ensuring Access to Medicaid Services (CMS-2442-F); New York Medicaid Consumer-Directed Personal Assistance Program; S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH USA, INC. via AVENUE SOLUTIONS
2025 · first_quarter · Q1
Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation; Issues related to healthcare access, quality and costs; Issues related to Medicare and Medicaid coverage and reimbursement; Medicare reimbursement for biosimilars
Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Issues related to the expiration/extension of Priority Review Vouchers (PRVs) for rare disease; Issues related to 340b drug pricing program; S. 891, Bipartisan Health Care Act H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via AVENUE SOLUTIONS
2025 · first_quarter · Q1
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 2199/S. 1173, Restore Protections for Dialysis Patients Act; S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES LLC via AVENUE SOLUTIONS
2025 · first_quarter · Q1
Issues related to the CMS Rule: Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4); Medicare coverage of breakthrough technologies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ALLIANCE FOR CARE AT HOME via AVENUE SOLUTIONS
2025 · first_quarter · RR
Issues related to home health, hospice, palliative, home and community based services.
VERTEX PHARMACEUTICALS INCORPORATED via AVENUE SOLUTIONS
2024 · fourth_quarter · Q4
H.R. 7142/S. 3832, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; S. 2973, The Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, The Lower Costs, More Transparency Act
Monitor S. 1339, Pharmacy Benefit Manager Reform Act; Monitor issues related to 340b; Expiring healthcare extenders; H.R. 10545, American Relief Act, 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITEDHEALTH GROUP INC via AVENUE SOLUTIONS
2024 · fourth_quarter · Q4
Issues pertaining to CHANGE cyber attack; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Telehealth extension; Issues related to Medicare provider directories; Issues related to Medicare Advantage marketing practices, prior authorization; S. 2973, Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, Lower Costs, More Transparency Act; Issues related to 2025 Medicare Part D Bid Information and Announces Premium Stabilization Demonstration; Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs (Rate Notice); Issues related to the use of AI and it's correlation to prior authorization and utilization management policies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SNP ALLIANCE INC via AVENUE SOLUTIONS
2024 · fourth_quarter · Q4
Medicare and Medicaid dual eligible integration; Performance evaluation/quality oversight; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices; S. 3950, Delivering Unified Access to Lifesaving Services (DUALS) Act of 2024; Issues related to Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs (Rate Notice); Congressional briefing on SNP Supplemental Benefits; Expiring healthcare extenders; H.R. 10545, American Relief Act, 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SIEMENS MEDICAL SOLUTIONS USA, INC. via AVENUE SOLUTIONS
2024 · fourth_quarter · Q4
Issues related to healthcare data privacy; Issues related to Artificial Intelligence including Medicare reimbursement; Expiring healthcare extenders; H.R. 10545, American Relief Act, 2025
Monitor issues related to Medicare reimbursement for diagnostics; Monitor issues related to site neutral payments; Monitor issues related to physician payment cuts; Monitor issues related to clinical lab tests
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via AVENUE SOLUTIONS
2024 · fourth_quarter · Q4
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices and provider directories; Issues related to 2024 Medicare Advantage star ratings; S. 3950, Delivering Unified Access to Lifesaving Services (DUALS) Act of 2024; Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs (Rate Notice); Issues related to Medcare Advantage prior authorization; Expiring healthcare extenders; H.R. 10545, American Relief Act, 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAGE THERAPEUTICS, INC. via AVENUE SOLUTIONS
2024 · fourth_quarter · 4T
Education and awareness of mental health and maternal mental health issues, particularly postpartum depression; H.R. 3312/S. 1602, Moms Matter Act; Monitor DEA telemedicine prescribing of controlled substances extension; CMMI's Transforming Maternal Health (TMaH) Model; Issues related to 340b reform; Issues related to the formation of the Bipartisan Mental Health Caucus; H.R. 10545, American Relief Act, 2025
Filing targets: Substance Abuse & Mental Health Services Administration (SAMHSA)
PEDIATRIX MEDICAL GROUP, INC. via AVENUE SOLUTIONS
2024 · fourth_quarter · Q4
Implementation of the No Surprises Act (PL 116-260); Issues related to physician payment cuts; SFC white paper entitled, "Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B"; H.R. 5486/S. 2819, Access to Donor Milk Act of 2023; Issues related to GME and physician workforce shortages; Issues related to NIH study on baby formula and necrotizing enterocolitis; H.R. 10545, American Relief Act, 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CARE PARTNERS via AVENUE SOLUTIONS
2024 · fourth_quarter · Q4
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act; Adjustment of the Prospective Payment System (PPS) payment rate after the Transitional Drug Add-on Payment Adjustment (TDAPA) period ends for new drugs and biological products CMS determines are within an existing End-Stage Renal Disease (ESRD) functional category; Creation of incentives to adopt innovation for patients enrolled in Medicare Advantage plans; H.R. 5074/S. 4510, Kidney PATIENT Act of 2023; H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023; H.R. 10545, American Relief Act, 2025; Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model (11/6/23)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
JPMORGAN CHASE HOLDINGS LLC via AVENUE SOLUTIONS
2024 · fourth_quarter · Q4
Issues related to employer sponsored health care; Issues related to healthcare workforce shortages; Issues related to artificial intelligence, and healthcare data privacy; H.R. 10545, American Relief Act, 2025
Filing targets: SENATE
INCYTE CORPORATION via AVENUE SOLUTIONS
2024 · fourth_quarter · Q4
Issues related to 340b; Issues related to Tricare coverage for Vitiligo; H.R. 10545, American Relief Act, 2025
Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation; Issues related to Medicaid coverage for Vitiligo; Issues related to healthcare access, quality and costs; Issues related to Medicaid rebates
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HELP AT HOME via AVENUE SOLUTIONS
2024 · fourth_quarter · Q4
Issues related to home care and home and community based services (HCBS); Ensuring Access to Medicaid Services (CMS-2442-F); New York Medicaid Consumer-Directed Personal Assistance Program; H.R. 10545, American Relief Act, 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE LEADERSHIP COUNCIL via AVENUE SOLUTIONS
2024 · fourth_quarter · 4T
Monitor implementation of healthcare quality, cost, and access and related healthcare reform efforts; Healthcare workforce shortage issues; Issues related to cybersecurity in the healthcare sector; Issue related to artificial intelligence in the healthcare sector; H.R. 10545, American Relief Act, 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH USA, INC. via AVENUE SOLUTIONS
2024 · fourth_quarter · Q4
Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation; Issues related to healthcare access, quality and costs; Issues related to Medicare and Medicaid coverage and reimbursement; Medicare reimbursement for biosimilars
Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Issues related to the expiration/extension of Priority Review Vouchers (PRVs) for rare disease; Issues related to 340b drug pricing program; H.R. 10545, American Relief Act, 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via AVENUE SOLUTIONS
2024 · fourth_quarter · Q4
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 6860/S. 5018, the Restore Protections for Dialysis Patients Act; H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023; H.R. 5074/S. 4510, Kidney PATIENT Act of 2023; H.R. 10545, American Relief Act, 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES LLC via AVENUE SOLUTIONS
2024 · fourth_quarter · Q4
Issues related to the CMS Rule: Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 8816, American Medical Innovation and Investment Act of 2024; H.R. 10545, American Relief Act, 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION, INC. via AVENUE SOLUTIONS
2024 · fourth_quarter · 4T
Telehealth extension; Issues related to site neutral payments; Issues related to prior authorization in Medicare Advantage; Issues related to physician payment reform; SFC white paper entitled, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 5526/S.3458, Seniors Access to Critical Medications Act of 2023; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; S. 2764/H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; H.R. 5378, The Lower Costs, More Transparency Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN MEDICAL ASSOCIATION via AVENUE SOLUTIONS
2024 · fourth_quarter · Q4
Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3561, PATIENT Act of 2023; H.R. 3284, Providers and Payers COMPETE Act; H.R. 4822, Health Care Price Transparency Act of 2023; S. 3503, Value in Healthcare Act; SFC white paper entitled, Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B; Issues related to physician payment cuts; H.R. 1770/S. 2477, Equitable Community Access to Pharmacist Services Act; H.R. 10545, American Relief Act, 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMEDISYS HOME HEALTH AND HOSPICE CARE via AVENUE SOLUTIONS
2024 · fourth_quarter · Q4
Payment issues related to Medicare Home Health benefit; S. 2137/H.R. 5159, Preserving Access to Home Health Act; CMS-1803-P, or the CY 2025 Home Health Prospective Payment System Rate Update; H.R. 9803, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act; H.R. 10545, American Relief Act, 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VERTEX PHARMACEUTICALS INCORPORATED via AVENUE SOLUTIONS
2024 · third_quarter · Q3
Monitor S. 1339, Pharmacy Benefit Manager Reform Act; Monitor issues related to 340b; Expiring healthcare extenders
H.R. 7142/S. 3832, Alternatives to PAIN Act and issues related to payment policies for non-opioid pain medication; S. 2973, The Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, The Lower Costs, More Transparency Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITEDHEALTH GROUP INC via AVENUE SOLUTIONS
2024 · third_quarter · Q3
Issues pertaining to CHANGE cyber attack; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Telehealth extension; Issues related to Medicare provider directories; Issues related to Medicare Advantage marketing practices, prior authorization; S. 2973, Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, Lower Costs, More Transparency Act; Issues related to 2025 Medicare Part D Bid Information and Announces Premium Stabilization Demonstration; Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs (Rate Notice); Issues related to the use of AI and it's correlation to prior authorization and utilization management policies
Issues related to CHANGE cyber attack; Issues related to healthcare transparency and consolidation; S. 1339, The Pharmacy Benefit Manager Reform Act; Issues related to cybersecurity, artificial intelligence, and healthcare data privacy; Expiring healthcare extenders
SNP ALLIANCE INC via AVENUE SOLUTIONS
2024 · third_quarter · Q3
Medicare and Medicaid dual eligible integration; Performance evaluation/quality oversight; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices; S. 3950, Delivering Unified Access to Lifesaving Services (DUALS) Act of 2024; Issues related to Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs (Rate Notice); Congressional briefing on SNP Supplemental Benefits; Expiring healthcare extenders
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via AVENUE SOLUTIONS
2024 · third_quarter · Q3
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices and provider directories; Issues related to 2024 Medicare Advantage star ratings; S. 3950, Delivering Unified Access to Lifesaving Services (DUALS) Act of 2024; Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs (Rate Notice); Issues related to Medcare Advantage prior authorization; Expiring healthcare extenders
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SAGE THERAPEUTICS, INC. via AVENUE SOLUTIONS
2024 · third_quarter · Q3
Education and awareness of mental health and maternal mental health issues, particularly postpartum depression; H.R. 3312/S. 1602, Moms Matter Act; Monitor DEA telemedicine prescribing extension; CMMI's Transforming Maternal Health (TMaH) Model; Issues related to 340b reform; Issues related to the formation of the Bipartisan Mental Health Caucus
Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation; Expiring healthcare extenders; Issues related to PBM reforms
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PEDIATRIX MEDICAL GROUP, INC. via AVENUE SOLUTIONS
2024 · third_quarter · Q3
Implementation of the No Surprises Act (PL 116-260); Issues related to physician payment cuts; SFC white paper entitled, "Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B"; H.R. 5486/S. 2819, Access to Donor Milk Act of 2023; Issues related to GME and physician workforce shortages; Issues related to NIH study on baby formula and necrotizing enterocolitis
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) via AVENUE SOLUTIONS
2024 · third_quarter · Q3
H.R. 5391/S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act; Access and reimbursement of Part B Drugs in Medicare; Continued expansion of Telehealth services including in H.R. 3875/S. 3967, Expanded Telehealth Access Act and Telehealth Modernization Act; H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency Act (PATIENT Act) of 2023; H.R. 4822, Health Care Price Transparency Act of 2023; Support for site neutrality policies in H.R. 5378, Lower Costs, More Transparency Act; Implementation of provisions included in Subtitle B of PL. 117-169 - Inflation Reduction Act of 2022; Issues related to MACRA Reform including H.R. 2474, Strengthening Medicare for Patients and Providers Act; Support the passage of H.R. 5526/S. 3458, the Seniors' Access to Critical Medications Act; H.R. 6683, Preserving Seniors Access to Physicians Act of 2023; Issues related to prior authorization in H.R. 8702/S. 4518, Improving Seniors Timely Access to Care Act of 2024
Issues related to 340b; S. 1339, The Pharmacy Benefit Manager Reform Act
KIDNEY CARE PARTNERS via AVENUE SOLUTIONS
2024 · third_quarter · Q3
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act; Adjustment of the Prospective Payment System (PPS) payment rate after the Transitional Drug Add-on Payment Adjustment (TDAPA) period ends for new drugs and biological products CMS determines are within an existing End-Stage Renal Disease (ESRD) functional category; Creation of incentives to adopt innovation for patients enrolled in Medicare Advantage plans; H.R. 5074/S. 4510, Kidney PATIENT Act of 2023; H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023; Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model (11/6/23)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INCYTE CORPORATION via AVENUE SOLUTIONS
2024 · third_quarter · Q3
Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation; Issues related to Medicaid coverage for Vitiligo; Issues related to healthcare access, quality and costs
Issues related to 340b
Issues related to TRICARE coverage of vitiligo
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HELP AT HOME via AVENUE SOLUTIONS
2024 · third_quarter · Q3
Issues related to home care and home and community based services (HCBS); Ensuring Access to Medicaid Services (CMS-2442-F); New York Medicaid Consumer-Directed Personal Assistance Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHCARE LEADERSHIP COUNCIL via AVENUE SOLUTIONS
2024 · third_quarter · Q3
Monitor implementation of healthcare quality, cost, and access and related healthcare reform efforts; Healthcare workforce shortage issues; Issues related to cybersecurity in the healthcare sector; Issue related to artificial intelligence in the healthcare sector
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GRAIL, INC. via AVENUE SOLUTIONS
2024 · third_quarter · Q3
Issues related to multi-cancer early detection screening; H.R. 2407, Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; S. 2085, Medicare Multi-Cancer Early Detection Screening Coverage Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH USA, INC. via AVENUE SOLUTIONS
2024 · third_quarter · Q3
Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Issues related to the expiration/extension of Priority Review Vouchers (PRVs) for rare disease; Issues related to 340b drug pricing program
Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation; Issues related to healthcare access, quality and costs; Issues related to Medicare and Medicaid coverage and reimbursement; Medicare reimbursement for biosimilars
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via AVENUE SOLUTIONS
2024 · third_quarter · Q3
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 6860/S. 5018, the Restore Protections for Dialysis Patients Act; H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023; H.R. 5074/S. 4510, Kidney PATIENT Act of 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EDWARDS LIFESCIENCES LLC via AVENUE SOLUTIONS
2024 · third_quarter · Q3
Issues related to the CMS Rule: Medicare Coverage of Innovative Technology; Issues related to Transitional Coverage for Emerging Technologies (TCET) (CMS-3421); H.R. 8816, American Medical Innovation and Investment Act of 2024
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMEDISYS HOME HEALTH AND HOSPICE CARE via AVENUE SOLUTIONS
2024 · third_quarter · Q3
Payment issues related to Medicare Home Health benefit; S. 2137/H.R. 5159, Preserving Access to Home Health Act; CMS-1803-P, or the CY 2025 Home Health Prospective Payment System Rate Update; H.R. 9803, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act
Filing targets: HOUSE OF REPRESENTATIVES
HEALTHCARE LEADERSHIP COUNCIL via AVENUE SOLUTIONS
2024 · second_quarter · Q2
Monitor implementation of healthcare quality, cost, and access and related healthcare reform efforts; Healthcare workforce shortage issues; Issues related to cybersecurity and CHANGE Healthcare breach; Issue related to artificial intelligence in the healthcare sector;
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SNP ALLIANCE INC via AVENUE SOLUTIONS
2024 · second_quarter · Q2
Medicare and Medicaid dual eligible integration; Performance evaluation/quality oversight; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices; S. 3950, Delivering Unified Access to Lifesaving Services (DUALS) Act of 2024; Issues related to Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs (Rate Notice); Congressional briefing on SNP Supplemental Benefits
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SCAN HEALTH PLAN via AVENUE SOLUTIONS
2024 · second_quarter · Q2
Medicare and Medicaid dual eligible integration; Monitoring of Medicare Advantage, particularly as it relates to changes in coding intensity, benchmarks, and health risk assessments; Issues related to Medicare Advantage marketing practices and provider directories; Issues related to 2024 Medicare Advantage star ratings; S. 3950, Delivering Unified Access to Lifesaving Services (DUALS) Act of 2024; Calendar Year (CY) 2025 Rate Announcement for the Medicare Advantage (MA) and Medicare Part D Prescription Drug (Part D) Programs (Rate Notice); Issues related to Medcare Advantage prior authorization
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SAGE THERAPEUTICS, INC. via AVENUE SOLUTIONS
2024 · second_quarter · Q2
Education and awareness of mental health and maternal mental health issues, particularly postpartum depression; H.R. 3312/S. 1602, Moms Matter Act; Monitor DEA telemedicine prescribing extension; CMMI's Transforming Maternal Health (TMaH) Model; Issues related to 340b reform
Filing targets: HOUSE OF REPRESENTATIVES, Office of the Vice President of the United States, SENATE
KIDNEY CARE PARTNERS via AVENUE SOLUTIONS
2024 · second_quarter · Q2
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 6860, Restore Protections for Dialysis Patients Act; Adjustment of the Prospective Payment System (PPS) payment rate after the Transitional Drug Add-on Payment Adjustment (TDAPA) period ends for new drugs and biological products CMS determines are within an existing End-Stage Renal Disease (ESRD) functional category; Creation of incentives to adopt innovation for patients enrolled in Medicare Advantage plans; H.R. 5074/S. 4510, Kidney PATIENT Act of 2023; H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023; Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model (11/6/23)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FRESENIUS MEDICAL CARE NORTH AMERICA via AVENUE SOLUTIONS
2024 · second_quarter · Q2
Issues related to End Stage Renal Disease (ESRD) and Chronic Kidney Disease; H.R. 6860, the Restore Protections for Dialysis Patients Act; H.R. 5027/S. 4469, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023; H.R. 5074/S. 4510, Kidney PATIENT Act of 2023
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MERCK & CO. INC. via AVENUE SOLUTIONS
2024 · first_quarter · Q1
Value of prescription drugs; Issues related to Medicare Parts B and D; Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation; S. 2973, The Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, The Lower Costs, More Transparency Act; Issues related to Medicaid Drug Rebate Program
Antibiotics/stewardship; S.1355/H.R.2940, PASTEUR Act of 2023; Value of prescription drugs; Issues related to the Vaccine Injury Compensation Program (VICP); Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation; Issues related to HPV vaccine and ACIP recommendations; Expiring healthcare extenders; S. 1339, The Pharmacy Benefit Manager Reform Act; H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42); H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47); Issues related to 340b
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA) via AVENUE SOLUTIONS
2024 · first_quarter · Q1
Expiring healthcare extenders; S. 1339, The Pharmacy Benefit Manager Reform Act; Issues related to 340b; H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42); H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47)
Telehealth extension; Issues related to site neutral payments; Issues related to healthcare transparency and consolidation; Issues related to Medical Economic Index (MEI) in the 2023 Physician Fee Schedule Rule; H.R. 2474, Strengthening Medicare for Patients and Providers Act; H.R. 3284, Providers and Payers COMPETE Act; Issues related to physician payment cuts; Issues related to prior authorization in Medicare Advantage; H.R. 5526 / S. 3458, Seniors Access to Critical Medications Act of 2023; S. 2764 / H.R. 5391, Protecting Patient Access to Cancer and Complex Therapies Act of 2023; S. 2973, Modernizing and Ensuring PBM Accountability (MEPA) Act; H.R. 5378, Lower Costs, More Transparency Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CARE PARTNERS via AVENUE SOLUTIONS
2024 · first_quarter · Q1
Issues relating to End Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD); H.R. 6860, Restore Protections for Dialysis Patients Act; Adjustment of the Prospective Payment System (PPS) payment rate after the Transitional Drug Add-on Payment Adjustment (TDAPA) period ends for new drugs and biological products CMS determines are within an existing End-Stage Renal Disease (ESRD) functional category; Creation of incentives to adopt innovation for patients enrolled in Medicare Advantage plans; H.R. 5074, Kidney PATIENT Act of 2023; H.R. 5027, Chronic Kidney Disease Improvement in Research and Treatment Act of 2023; Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model (11/6/23)
Expiring healthcare extenders; H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42); H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47)
KARUNA THERAPEUTICS, INC. via AVENUE SOLUTIONS
2024 · first_quarter · Q1
Education around innovation in schizophrenia; Issues related to mental health; Expiring healthcare extenders; H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42); H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47)
Filing targets: SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE